Profiel
Matthew T.
Seibt worked as the Chief Commercial Officer at Acer Therapeutics, Inc. from 2019 to 2023.
Prior to that, he held a former job at the same company from 2018.
He received his undergraduate degree from The University of Texas at Austin.
Eerdere bekende functies van Matthew T. Seibt
| Bedrijven | Functie | Einde |
|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01-03-2023 |
Opleiding van Matthew T. Seibt
| The University of Texas at Austin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
